These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36277378)

  • 1. The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization.
    Tong Q; Li R; Wang R; Zuo C; Li D; Jia G; Peng Y; Li X; Yang J; Xue S; Bai Q; Li X
    Front Bioeng Biotechnol; 2022; 10():1021499. PubMed ID: 36277378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silk fibroin-based embolic agent for transhepatic artery embolization with multiple therapeutic potentials.
    Shi L; Li D; Tong Q; Jia G; Li X; Zhang L; Han Q; Li R; Zuo C; Zhang W; Li X
    J Nanobiotechnology; 2023 Aug; 21(1):278. PubMed ID: 37598140
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wu X; Ge L; Shen G; He Y; Xu Z; Li D; Mu C; Zhao L; Zhang W
    ACS Appl Mater Interfaces; 2022 May; 14(19):21848-21859. PubMed ID: 35507826
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life.
    Agirrezabal I; Brennan VK; Colaone F; Shergill S; Pereira H; Chatellier G; Vilgrain V
    Adv Ther; 2022 May; 39(5):2035-2051. PubMed ID: 35279814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [
    Josefsson A; Cortez AG; Rajkumar H; Latoche JD; Jaswal AP; Day KE; Zarisfi M; Rigatti LH; Huang Z; Nedrow JR
    EJNMMI Radiopharm Chem; 2023 Aug; 8(1):19. PubMed ID: 37578558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib.
    Teyateeti A; Mahvash A; Long J; Abdelsalam M; Avritscher R; Kaseb A; Odisio B; Ravizzini G; Surasi D; Teyateeti A; Macapinlac H; Kappadath SC
    World J Gastroenterol; 2021 Dec; 27(47):8166-8181. PubMed ID: 35068861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of transarterial radioembolization.
    Mahnken AH
    World J Radiol; 2016 May; 8(5):449-59. PubMed ID: 27247711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments.
    Cappelli A; Pettinato C; Golfieri R
    J Hepatocell Carcinoma; 2014; 1():163-82. PubMed ID: 27508185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion.
    McGee HM; King MJ; Özbek U; Olson A; Kim E; Fischman AM; Schwartz M; Rosenzweig KE; Buckstein M
    Am J Clin Oncol; 2019 Apr; 42(4):367-374. PubMed ID: 30724782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Salem R; Lewandowski RJ
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
    Kim DY; Han KH
    Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.
    Moreno-Luna LE; Yang JD; Sanchez W; Paz-Fumagalli R; Harnois DM; Mettler TA; Gansen DN; de Groen PC; Lazaridis KN; Narayanan Menon KV; Larusso NF; Alberts SR; Gores GJ; Fleming CJ; Slettedahl SW; Harmsen WS; Therneau TM; Wiseman GA; Andrews JC; Roberts LR
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):714-23. PubMed ID: 23093355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial Radioembolization (TARE) with
    Patel A; Subbanna I; Bhargavi V; Swamy S; Kallur KG; Patil S
    South Asian J Cancer; 2021 Apr; 10(2):81-86. PubMed ID: 34568220
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series.
    Rose SC; Narsinh KH; Newton IG
    J Vasc Interv Radiol; 2017 Jan; 28(1):103-110. PubMed ID: 27840042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    Katsanos K; Kitrou P; Spiliopoulos S; Maroulis I; Petsas T; Karnabatidis D
    PLoS One; 2017; 12(9):e0184597. PubMed ID: 28934265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation.
    Zori AG; Ismael MN; Limaye AR; Firpi R; Morelli G; Soldevila-Pico C; Suman A; Vogel JD; Lazarowicz M; Geller BS; Toskich B; Gonzalo DH; Johnson MW; Cabrera R
    Am J Clin Oncol; 2020 May; 43(5):325-333. PubMed ID: 32079854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?
    El Fouly A; Ertle J; El Dorry A; Shaker MK; Dechêne A; Abdella H; Mueller S; Barakat E; Lauenstein T; Bockisch A; Gerken G; Schlaak JF
    Liver Int; 2015 Feb; 35(2):627-35. PubMed ID: 25040497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer.
    Li R; Li D; Jia G; Li X; Sun G; Zuo C
    Front Oncol; 2020; 10():551622. PubMed ID: 33569342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.